Shalom Life | June 05, 2014

Israeli Researchers Discover New Method to Prevent Alzheimer's

Researchers claim stopping the brain from aging is a major step forward towards halting Alzheimer's from spreading

By: No Camels Team

Published: December 5th, 2013 in Health » Israel

Forever young? Neurodegenerative disease, such as Alzheimer’s and Parkinson’s, are most likely to occur in older people. Researchers at the Hebrew University of Jerusalem, alongside an Israeli startup called TyrNovo, have made a major step towards halting these diseases – by essentially stopping the brain from aging.

The researchers, led by Doctor Ehud Cohen, found that TyrNovo’s novel and unique compound, named NT219, selectively inhibits the process of aging in order to protect the brain from neurodegenerative diseases, without affecting lifespan. This is a first and important step towards the development of future drugs for the treatment of various neurodegenerative maladies.

Human neurodegenerative diseases such as Alzheimer’s, Parkinson’s and Huntington’s diseases share two key features: they stem from toxic protein aggregation and emerge late in life. As humans age, the mechanism regulating protective mechanisms that prevent the manifestation of the toxic proteins start to fail, making the elderly exposed to disease.

From worms, to mice, to men

Cohen’s first breakthrough in this area occurred when he discovered, working with worms, that reducing the activity of the signaling mechanism conveyed through insulin and a hormone called IGF1, constituted a defense against the aggregation of a protein which is mechanistically-linked with Alzheimer’s disease. Later, he found that the inhibition of this signaling route also protected Alzheimer’s-model mice from behavioral impairments and pathological phenomena typical to the disease. In these studies, the path was reduced through genetic manipulation, a method not applicable in humans.

Dr. Hadas Reuveni, the CEO of TyrNovo, a startup company formed for the clinical development of NT219, and Profesor Alexander Levitzki from the Department of Biological Chemistry at the Hebrew University, with their research teams, discovered a new set of compounds that inhibit the activity of the IGF1 signaling cascade in a unique and efficient mechanism, primarily for cancer treatment, and defined NT219 as the leading compound for further development.

Now, in a fruitful collaboration Cohen and Reuveni, together with Cohen’s associates Tayir El-Ami and Lorna Moll, have demonstrated that NT219 efficiently inhibits IGF1 signaling, in both worms and human cells. The inhibition of this signaling pathway by NT219 protected worms from toxic protein aggregation that in humans is associated with the development of Alzheimer’s or Huntington’s disease.

Treating the untreatable

Recently, Cohen’s laboratory obtained an ethical approval to test the therapeutic efficiency of NT219 as a treatment in Alzheimer’s-model mice, hoping to develop a future treatment for neurodegenerative disorders that currently cannot be treated.

Cohen is a member of the Department of Biochemistry and Molecular Biology, at the Institute for Medical Research Israel-Canada in the Hebrew University of Jerusalem’s Faculty of Medicine. The project was funded by the Rosetrees Trust of Britain. The findings were published this week in the journal Aging Cell.

This story is published on No Camels - Israeli Innovation News

Chicago Suing Israel’s Teva Trending Israelis Develop First Blood Test for Breast Cancer Trending Israeli Nonprofit Looks to Develop World's First Kid-Friendly Wheelchair Trending
 

California University Joins BDS Movement Against Israel

June 05, 2014 | By Shaleni McBain
California University Joins BDS Movement Against Israel

Students from the University of California, Santa Cruz have called for a divestment of American companies involved in 'human rights' abuse allegations

Read More

Chicago Suing Israel’s Teva

June 05, 2014 | By Shaleni McBain
Chicago Suing Israel’s Teva

The third largest city in the U.S. claims the Israeli company is excessively promoting painkillers, particularly opium

Read More

UK’s Largest Water Company Upgrading With Israeli Technology

June 05, 2014 | By Shaleni McBain
UK’s Largest Water Company Upgrading With Israeli Technology

United Utilities is hoping to become more energy efficient

Read More

Study: Gay Religious Jews Lead Double Life

June 05, 2014 | By Ynet News
Study: Gay Religious Jews Lead Double Life

A survey suggests that two-thirds of Israel's ultra-Orthodox homosexuals choose to marry women despite their sexual inclination

Read More

Israeli CEO's Welcome Students to Birthright Excel

June 05, 2014 | By Shalom Life Team

The new Taglit program offers select students from North America amazing internship opportunities in the Holy Land

Read More

Cleveland Gas Station Displaying Offensive anti-Semitic Mural

June 05, 2014 | By Shalom Life Team
Cleveland Gas Station Displaying Offensive anti-Semitic Mural

The gas station is owned by Palestinian-American Brahim "Abe" Avad

Read More

New Stage Show Features a Coven of Lena Dunhams

June 04, 2014 | By Sarah Bauder
New Stage Show Features a Coven of Lena Dunhams

'Too Many Lenas 3: Let Them Eat Cake' will play in New York later this month.

Read More

Steven Spielberg’s Niece to Compete on ‘The Voice’ Israel [VIDEO]

June 04, 2014 | By Ashley Baylen
Steven Spielberg’s Niece to Compete on ‘The Voice’ Israel [VIDEO]

Jessy Katz performs Lykki Li's 'I Follow Rivers' in new teaser trailer.

Read More

More Headlines